Spectrum of cancer patients receiving renal biopsy.

[1]  C. Tsioufis,et al.  Arterial hypertension in patients under antineoplastic therapy: a systematic review , 2019, Journal of Hypertension.

[2]  M. Volpe,et al.  Arterial hypertension in cancer: The elephant in the room. , 2019, International journal of cardiology.

[3]  V. Baracos,et al.  Cancer cachexia: Diagnosis, assessment, and treatment. , 2018, Critical reviews in oncology/hematology.

[4]  Xifeng Wu,et al.  Cancer risk associated with chronic diseases and disease markers: prospective cohort study , 2018, British Medical Journal.

[5]  M. Korc,et al.  Cancer-associated cachexia , 2018, Nature Reviews Disease Primers.

[6]  J. Thissen,et al.  Biomarkers of cancer cachexia. , 2017, Clinical biochemistry.

[7]  A. Webster,et al.  Chronic Kidney Disease , 2017, The Lancet.

[8]  J. Berns,et al.  The Native Kidney Biopsy: Update and Evidence for Best Practice. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[9]  T. Shanafelt,et al.  Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience , 2015, Haematologica.

[10]  L. Ferrari,et al.  Arterial hypertension and cancer , 2014, International journal of cancer.

[11]  Zhi-Hong Liu,et al.  Renal Involvement in Non-Hodgkin Lymphoma: Proven by Renal Biopsy , 2014, PloS one.

[12]  C. Paul,et al.  A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use , 2014, Kidney international.

[13]  T. Choueiri,et al.  Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives. , 2013, Trends in cardiovascular medicine.

[14]  P. Ronco,et al.  Onco-nephrology: glomerular diseases with cancer. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[15]  Jen‐Hau Chen,et al.  Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[16]  L. Lai,et al.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis , 2011, Nature Reviews Nephrology.

[17]  M. Praga,et al.  Acute interstitial nephritis. , 2010, Kidney international.

[18]  C. Elie,et al.  Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  T. Hewitson.  Renal tubulointerstitial fibrosis: common but never simple. , 2009, American journal of physiology. Renal physiology.

[20]  P. Mitchell,et al.  Association of CKD and cancer risk in older people. , 2009, Journal of the American Society of Nephrology : JASN.

[21]  J. Bacchetta,et al.  Paraneoplastic glomerular diseases and malignancies. , 2009, Critical reviews in oncology/hematology.

[22]  Ivar Heuch,et al.  Association of albuminuria and cancer incidence. , 2008, Journal of the American Society of Nephrology : JASN.

[23]  C. Alpers,et al.  VEGF inhibition and renal thrombotic microangiopathy. , 2008, The New England journal of medicine.

[24]  S. Oudard,et al.  Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management , 2007, Cancer.

[25]  Sudhir V. Shah,et al.  Improving outcomes from acute kidney injury: report of an initiative , 2007, Pediatric Nephrology.

[26]  H. Baelde,et al.  Role of the VEGF-A Signaling Pathway in the Glomerulus: Evidence for Crosstalk between Components of the Glomerular Filtration Barrier , 2007, Nephron Physiology.

[27]  B. Stengel,et al.  Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. , 2006, Kidney international.

[28]  C. Stehouwer,et al.  Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. , 2006, Journal of the American Society of Nephrology : JASN.

[29]  Richard J. Johnson,et al.  Tubulointerstitial damage and progression of renal failure. , 2005, Kidney international. Supplement.

[30]  M. Nangaku.  Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[31]  C. Usal,et al.  Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. , 2005, Kidney international.

[32]  D. Levy,et al.  Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.

[33]  V. Tesar,et al.  Secondary Membranous Nephropathy—One Center Experience , 2005, Renal failure.

[34]  B. Brenner,et al.  Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy , 2004, Circulation.

[35]  Jeffrey W. Clark,et al.  Gemcitabine‐associated thrombotic microangiopathy , 2004, Cancer.

[36]  H. Storm,et al.  Glomerulonephritis and malignancy: a population-based analysis. , 2003, Kidney international.

[37]  U. Goldbourt,et al.  Is there an association between hypertension and cancer mortality? , 2002, The American journal of medicine.

[38]  B. Neyns,et al.  Pamidronate-Related Nephrotoxicity (Tubulointerstitial Nephritis) in a Patient with Osteolytic Bone Metastases , 2001, Nephron.

[39]  P. Ronco,et al.  Paraneoplastic glomerulopathies: new insights into an old entity. , 1999, Kidney international.

[40]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[41]  K. Taub,et al.  Percutaneous renal biopsy utilizing real time, ultrasonic guidance and a semiautomated biopsy device. , 1990, Kidney international.

[42]  A. Matas,et al.  INCREASED INCIDENCE OF MALIGNANCY DURING CHRONIC RENAL FAILURE , 1975, The Lancet.

[43]  Amit X Garg,et al.  Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. , 2015, CMAJ open.

[44]  P. Mitchell,et al.  Reduced estimated GFR and cancer mortality. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  C. Usal,et al.  Induction of T regulatory cells attenuates idiopathic nephrotic syndrome. , 2009, Journal of the American Society of Nephrology : JASN.

[46]  M. Perazella,et al.  Bisphosphonate nephrotoxicity. , 2008, Kidney international.

[47]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  M. Madaio.  Renal biopsy. , 1990, Kidney international.